Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 281

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

A Pilot Clinical Trial of Oral Pentosan Polysulfate And Oral Hydroxyzine in Patients With Interstitial Cystitis

SANT, G.R., PROPERT, K.J., HANNO, P.M., BURKS, D., CULKIN, D., DIOKNO, A.C., HARDY, C., LANDIS, J.R., MAYER, R., MADIGAN, R., MESSING, E.M., PETERS, K., THEOHARIDES, T.C., WARREN, J., WEIN, A.J., STEERS, W., KUSEK, J.W., NYBERG, L.M., the Interstitial Cystitis Clinical Trials Group · 2003 · Journal of Urology

Abstract

PURPOSE: This pilot study was designed to evaluate the feasibility of a multicenter, randomized, clinical trial in interstitial cystitis (IC). Secondary objectives were to evaluate the safety and efficacy of oral pentosan polysulfate sodium (PPS), hydroxyzine, and the combination to consider their use in a larger randomized clinical trial. MATERIALS AND METHODS: A 2 x 2 factorial study design was used to evaluate PPS and hydroxyzine. Participants met the National Institutes of Health-National Institute for Diabetes and Digestive and Kidney Diseases criteria for IC and reported at least moderate pain and frequency for a minimum of 6 months before study entry. The primary end point was a patient reported global response assessment. Secondary end points included validated symptom indexes and patient reports of pain, urgency and frequency. The target sample size was 136 participants recruited during 10 months. RESULTS: A total of 121 (89% of goal) participants were randomized over 18 months and 79% provided complete followup data. The response rate for hydroxyzine was 31% for those treated and 20% for those not treated (p = 0.26). A nonsignificant trend was seen in the PPS treatment groups (34%) as compared to no PPS (18%, p = 0.064). There were no treatment differences for any of the secondary end points. Adverse events were mostly minor and similar to those in previous reports. CONCLUSIONS: The low global response rates for PPS and hydroxyzine suggest that neither provided benefit for the majority of patients with IC. This trial demonstrated the feasibility of conducting a multicenter randomized clinical trial in IC using uniform procedures and outcomes. However, slow recruitment underscored the difficulties of evaluating commonly available IC drugs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/01.ju.0000083020.06212.3d

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 16 references

Cited by

See all 281

Metadata

Authors
SANT, G. R., PROPERT, K. J., HANNO, P. M., BURKS, D., CULKIN, D., DIOKNO, A. C., HARDY, C., LANDIS, J. R., MAYER, R., MADIGAN, R., MESSING, E. M., PETERS, K., THEOHARIDES, T. C., WARREN, J., WEIN, A. J., STEERS, W., KUSEK, J. W., NYBERG, L. M., & the Interstitial Cystitis Clinical Trials Group
Venue
Journal of Urology
Published
2003-09
Volume
170
Issue
3
Pages
810-815
ISSN
  • 0022-5347 (ISSN-L)
  • 1527-3792
OpenAlex
W2007069784
Cited by
281
References
16
FWCI
12.41
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Pilot Clinical Trial of Oral Pentosan Polysulfate And Oral Hydroxyzine in Patients With Interstitial Cystitis. https://app.cochat.ai/papers/10.1097/01.ju.0000083020.06212.3d
The paper
SANT, G. R., PROPERT, K. J., HANNO, P. M., BURKS, D., CULKIN, D., DIOKNO, A. C., HARDY, C., LANDIS, J. R., MAYER, R., MADIGAN, R., MESSING, E. M., PETERS, K., THEOHARIDES, T. C., WARREN, J., WEIN, A. J., STEERS, W., KUSEK, J. W., NYBERG, L. M., & the Interstitial Cystitis Clinical Trials Group. (2003). A Pilot Clinical Trial of Oral Pentosan Polysulfate And Oral Hydroxyzine in Patients With Interstitial Cystitis. Journal of Urology. https://doi.org/10.1097/01.ju.0000083020.06212.3d

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.